Migraine Pathophysiology and Chemical Sensitivity
Migraine affects approximately 15% of the global population, causing episodic severe headache with neurological symptoms. Cortical spreading depression, trigeminal nerve activation, and vascular dysregulation are central mechanisms that may be influenced by environmental chemical exposures including PFAS.
PFAS and Vascular Function
PFAS alter endothelial nitric oxide synthase (eNOS) activity, affecting the vascular tone regulation critical to migraine pathophysiology. Impaired endothelial function from PFAS exposure may increase susceptibility to cortical spreading depression events that trigger migraine attacks in sensitized individuals.
Hormonal Interactions
Migraine strongly affects women, particularly in relation to hormonal fluctuations during menstruation and perimenopause. PFAS disruption of estrogen signaling—altering estrogen receptor sensitivity and hormone metabolism—may exacerbate hormonally triggered migraine patterns in susceptible women.
Neurological Sensitivity and Treatment Response
Neurologists treating migraine patients with high PFAS exposure may observe altered medication responses due to PFAS effects on drug metabolism and receptor function. Environmental exposure assessment and mitigation may be part of comprehensive migraine management, particularly for patients with unusual treatment resistance.